Taurine-Mediated Cardioprotection is Greater When Administered upon Reperfusion than Prior to Ischemia
Taurine (TA) administered exogenously before the induction of myocardial ischemia decreases lactic acid production and increases pyruvic acid production during ischemia. It also preserves the activity of GOT, GPT, LDH and CPK during ischemia and enhances recovery of CKMB synthesis as early as 5 minutes after onset of reperfusion. The aim of the study was to determine the optimal conditions for administering TA in order to reduce myocardial ischemia-reperfusion injury. Left ventricular (LV) function, creatine kinase (CK) and lipid peroxide products (LPOP=oxidant stress), as well as the area at risk (AAR), and infarct size (IS) after reperfusion were studied in 3 groups of isolated rat hearts perfused with Krebs Henseleit Buffer (KHB)-stabilized isolated rat hearts that were subjected to 20 minutes(’) of global ischemia at 37ô followed by 60′ of reperfusion with KHB: Hearts were perfused with TA containing KHB for 10′ just prior to ischemia or during the first 10’ of reperfusion. Conclusion:Taurine before ischemia or during reperfusion was equally effective in preventing infarction; however, when administered at reperfusion, taurine reduced lipid peroxidation and myocardial injury more, thereby providing improved early recovery of function.
KeywordsCreatine Kinase Infarct Size Lactic Acid Production Global Ischemia Adenylate Kinase
Unable to display preview. Download preview PDF.
- Beutner G, Rück A, Riede B, Brdiczka D (1998) Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1368:7–18Google Scholar
- Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, Jones J, Goldschmidt-Clermont PJ, Loscalzo J (2002) Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac functionand structure. Circulation 106: 1154–1158PubMedCrossRefGoogle Scholar
- Franconi F, Stendardi I, Failli P, Matucci R, Baccaro C, Montorsi L, BandinelliR, Giotti A (1985) The protective effects of taurine on hypoxia (performed in the absence of glucose) and on reoxygenation (in the presence of glucose) in guineapig heart. Biochem Pharmacol 34: 2611–2615PubMedCrossRefGoogle Scholar
- Hill MF, Singal PK (1997) Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction Circulation 96:2414–2420Google Scholar
- Koufen P, Rück A, Brdiczka D, Wendt S, Wallimann T, Stark G (1999) Free radical-induced inactivation of creatine kinase: influence on the octameric and dimeric states of the mitochondrial enzyme (Mib-CK). Biochem J 344 Pt 2:413–417Google Scholar
- Miyamoto TA, Miyamoto KJ, Miyamoto MR (2006) Systemically administered taurine Part III. Pharmacologically activated mechanisms. Adv Exp Med Biol 583:335–351Google Scholar
- Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, O’Gorman E, Rück A, Brdiczka D (1998) Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 8:229–234PubMedCrossRefGoogle Scholar
- Whalen DA Jr, Hamilton DG, Ganote CE, Jennings RB (1974) Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol 74:381–397Google Scholar